Application of structure‐based focusing to the estrogen receptor

We present the Cerius² Structure‐Based Focusing (SBF) application. This application was applied to the estrogen receptor. A series of three‐dimensional queries were generated for the binding site of the receptor. The queries consist of combinations of hydrogen bond donors and acceptors, and lipophilic features for the binding site along with excluded volume regions occupied by the receptor atoms. A database of 31 ligands with known relative binding affinities for the estrogen receptor was used to examine the selectivity of the queries. The objective of the study was to determine if queries generated by the Cerius² SBF method could differentiate between the more and less active ligands of the training set. Results are promising, with the generated queries showing greater selectivity toward the more active ligands. © 2001 John Wiley & Sons, Inc. J Comput Chem 22: 993–1003, 2001     

10-Ethyl-acridine-2-sulfonyl Chloride: A New Derivatization Agent for Enhancement of Atmospheric Pressure Chemical Ionization of Estrogens in Urine

The extensive metabolism and treatment of low doses of estrone (E1), estradiol (E2) and estriol (E3) in preclinical animal species necessitates a sensitive analytical method to identify or quantify the estrogens in biological matrixes. In this study, a highly sensitive and specific method based on the derivatization of E1, E2 and E3 with 10-ethyl-acridine-2-sulfonyl chloride (EASC) coupled with liquid chromatography-ion-trap mass spectrometry with APCI-MS (MRM) identification of estrogens has been developed. The EASC derivatization of E1, E2 and E3 introduces an acridine functional group into estrogen molecules. The carbonyl group in EASC core results in the formation of a phenoxide negative ion by the intramolecular keto-enol isomerization that can be accepted a [H]⁺ and readily ionized in commonly used LC mobile phases. Derivatives are sufficiently stable to be efficiently analyzed by LC-APCI-MS and show an intense protonated molecular ion at m/z [M+H]⁺ in positive-ion mode. The collision-induced dissociation of molecular ion forms a distinctive product ion at m/z 222.6, corresponding to the protonated 10-ethyl-acridine moiety. The selected reaction monitoring, based on the m/z [M+H]⁺ → m/z 222.6 transitions, is highly specific for estrogen derivatives. Therefore, the facile EASC derivatization coupling with LC-APCI-MS analysis allows the development of a highly sensitive and specific method for the identification of trace levels of estrogens in urine of root vole (Microtus oeconomus Pallas).     

Column-switching reversed phase-hydrophilic interaction liquid chromatography/tandem mass spectrometry method for determination of free estrogens and their conjugates in river water

We report a column-switching liquid chromatography (LC) tandem mass spectrometry (MS/MS) method for highly sensitive determination of both free estrogens (estrone, estradiol, and estriol) and their conjugates (estrone-3-sulfate, estradiol-3-sulfate, estriol-3-sulfate, estrone-3-glucuronide, estradiol-3-glucuronide, estriol-16-glucuronide, and estriol-3-glucuronide) in river water. This technique combines reversed phase (RP) chromatographic separation of the dansyl chloride derivatized free estrogens and hydrophilic interaction liquid chromatographic (HILIC) separation of the estrogen conjugates with multiple reaction monitoring (MRM). Using this new method, sensitivity increases 100- to 1000-fold for free estrogens and 2- to 10-fold for estrogen conjugates over RPLC-MS/MS alone. Method detection limits (MDL) range from 0.038 to 6.9 ng L⁻¹ with accuracy of 68-105% and precision of 1.7-17%. We successfully used this method to analyze river water samples collected from the North Saskatchewan River at the same location and detected trace concentrations of estrone (0.042 ng L⁻¹) and estrone-3-sulfate (0.84 ng L⁻¹), demonstrating the application of this method for environmental analysis.     

Liquid chromatography tandem mass spectrometry determination of free and conjugated estrogens in breast cancer patients before and after exemestane treatment

We report liquid chromatographic separation with tandem mass spectrometry determination of 12 endogenous estrogens and their intact conjugates in blood and urine and its application to study effects of exemestane treatment on estrogen generation and metabolism in postmenopausal women with estrogen-dependent breast cancer. A 0.5 mL aliquot of each urine or serum sample is fractionated with solid phase extraction to a fraction of free estrogen and another fraction of their conjugates. The reversed phase LC/MS/MS determines dansylated estrogens with positive ionization and intact conjugates with negative ionization. The method provides reproducible separation and limit of detection as low as 1 pg mL⁻¹ for free estrogens and 0.03 ng mg⁻¹ creatinine for the conjugates in serum and urine samples. The method enabled us to acquire unique concentration profiles of 12 endogenous estrogens and their intact conjugates in 30 breast cancer patients before and after one month of exemestane treatment. Exemestane suppressed total serum and urinary estrogens by 11–97% (P < 0.0001) and 8.7–91% (P < 0.0001), respectively. Specifically, these data show that exemestane preferentially suppressed E1, E1-3S, E1-3G, and E2-17G more than other estrogens. Linear regression analysis of estrogen concentrations before and after treatment showed correlation coefficients of 0.8385 (n = 289, P < 0.0001) and 0.8863 (n = 360, P < 0.0001). This study provides urinary and blood estrogen concentration profiles in breast cancer patients to demonstrate the effect of exemestane on estrogen generation, supporting inhibition of aromatase activity.     

Fluorescein labeling of estrogen for application of fluorescence polarization binding assays for antibody and receptor

The fluorescence polarization binding assay (FPBA) using fluorescein-labeled estrogen tracer is a homogeneous assay applicable to both estrogen antibody and estrogen receptor-binding assays. Two estrogen-ethylendiamine fluoresceinthiobamyl (E-EDF) tracers were synthesized; estrogen-6-EDF (E-6-F) derived from 6-ketoestradiol 6-(o-carboxymethyl) oxime and estrogen-17-EDF (E-17-F) was from 17β-estradiol 17-hemisuccinate. In both FPBAs using antibody and receptor, E-6-F tracer (Rf_365nm=0.58) showed a better binding response than E-17-F (Rf_365nm=0.70) indicating that the 17-position of estrogen seems to play an essential role as a binding site for antibody or receptor. In the optimized conditions of FPBA for E₂ using E-6-F tracer, antibody binding (K_d=9.4×10⁻⁹ M) is 50 times sensitive than receptor binding (K_d=4.6×10⁻⁸ M). Binding responses of estrogen and its related chemicals by FPBA indicate that antibody binding assay is able to screen the structural similarity of estrogen showing some response with methyltestosterone (K_i=2.1×10⁻⁵ M). On the other hand, the receptor assay is able to screen for estrogenic chemicals such as tamoxifen (K_i=4.5×10⁻⁹ M) and diethylstilbesterol (K_i=8.1×10⁻⁷ M). Therefore, E-6-F tracer is useful as a tracer for FPBA that is able to screen for chemicals structurally similar to estrogen using antibody, and that is able to screen for chemicals functionally similar to estrogen using receptor binding assay.     

Assessing selected estrogens and xenoestrogens in Brazilian surface waters by liquid chromatography-tandem mass spectrometry

A sensitive and specific method was developed and validated for the determination of estrogen and xenoestrogen in surface waters using liquid chromatography followed by tandem mass spectrometry. Chromatographic separation was performed using ammonium hydroxide solutions in water and in methanol as mobile phase. Compounds were determined in a triple quadrupole mass spectrometer equipped with an electrospray ionization interface operating in the negative mode. Multiple reaction monitoring conditions were optimized for estrone, 17β-estradiol, estriol, 17α-ethinylestradiol, bisphenol A, 4-n-octylphenol, and 4-n-nonylphenol. The method was linear from 0.1 ng L^− 1 to 10 µgL^− 1. Limits of quantification varied between 0.1 and 3.1 ng L^− 1 and recoveries for a 50 ng L^− 1 spiked-surface water solution varied between 72 and 140%. The method was successfully used to determine estrogen and xenoestrogen levels in Brazilian water samples collected along the Atibaia River Basin, in the State of São Paulo. Concentrations of estrogens varied from 2.2 to 39 ng L^− 1. Bisphenol A was the most frequently detected compound as well as the only xenoestrogen in the samples with concentrations between 25 and 84 ng L^− 1.     

Raman spectroscopic discrimination of estrogens

Estrogens are a group of steroid compounds found in the human body that are eventually discharged and ultimately end up in sewer effluents. Since these compounds can potentially affect the endocrine system its detection and quantification in sewer water is important. In this study, estrogens such as estrone (E1), estradiol (E2), estriol (E3), and ethynylestradiol (EE2) were discriminated and quantitated using Raman spectroscopy. Simulated Raman spectra were correlated with experimental data to identify unique marker peaks, which proved to be useful in differentiating each estrogen molecules. Among these marker peaks are Raman modes arising from hydroxyl groups of the estrogen molecules in the spectral region 3200–3700 cm⁻¹. Other Raman modes unique to each of the estrogen samples were also identified, including peaks at 1722 cm⁻¹ for E1 and 2109 cm⁻¹ for EE2, which corresponds to their distinctive structures each containing a different set of functional groups. To quantify the components of estrogen mixtures, the intensities of each identifying Raman bands, at 581 cm⁻¹ for E1, 546 cm⁻¹ for E2, 762 cm⁻¹ for E3 and 597 cm⁻¹ for EE2, were compared and normalized against the intensity of a common peak at 783 cm⁻¹. Quantitative analysis yielded most results within an acceptable 20% error.     

Synthesis, radiolabeling and in vivo biodistribution of diethylstilbestrol phosphate derivative (DES-P)

Diethylstilbestrol (DES) is a well known, nonsteroidal estrogen with high affinity for the estrogen receptor (ER). Today DES is used to treat breast and prostate cancers. A phosphate derivative of DES [Diethylstilbestrol diphosphate (DES-P)] which is specific to tumor cells consisting alkaline phosphatase enzyme was synthesized and labeled with ^99mTc using tin chloride as reducing agent. In vivo biological activity of ^99mTc labeled diethylstilbestrol phosphate compound (^99mTc-DES-P) was examined by biodistribution studies on Wistar Albino rats. Statistical evaluation was performed using SPSS 13 program. The percentage (%) radiolabeling yield of ^99mTc-DES-P and quality control studies were done by Thin Layer Radio Chromatography (TLRC). Results showed that, ^99mTc-DES-P may be proposed as an imaging agent for ER enriched tumors such as uterus and prostate and their metastases in bones.     

Treatment of wastewater having estrogen activity by ionizing radiation

Decomposition of endocrine disrupting chemicals (EDCs) in wastewater was investigated by use of ⁶⁰Co γ-ray. Estrogen activities of wastewaters were estimated by the yeast two-hybrid assay based on human or medaka estrogen receptors. The dose required for the elimination of estrogen activity of wastewater below 1 ng dm⁻³ was about 200 Gy (J kg⁻¹). The elimination dose of the estrogen activity depended on the amounts of total organic carbons in wastewater. The economic cost of the treatment process of EDCs using electron beam was estimated at 17 yen m⁻³.     

Liquid chromatography tandem mass spectrometry method for determination of fulvestrant in rat plasma and its application to pharmacokinetic studies of a novel fulvestrant microcrystal

Fulvestrant (‘Faslodex’), an estrogen receptor antagonist, is available for the treatment of advanced breast cancer. The oil-based vehicle of Faslodex can lead to various adverse effects. A novel fulvestrant microcrystal (aqueous suspension) was developed in this study to eliminate these adverse effects. A sensitive and robust liquid chromatography tandem mass spectrometry method was developed and validated for the determination of fulvestrant in rat plasma using supported-liquid extraction. The separation of fulvestrant was achieved on an Agilent SB-C₁₈ column (2.1 × 50 mm, 3.5 μm) with isocratic elution using fulvestrant-d3 as internal standard. Mass spectrometric detection was conducted in negative multiple reaction monitoring mode. Ion transitions were at m/z 605.5 → 427.5 for fulvestrant and m/z 608.5 → 430.5 for fulvestrant-d3. The excellent linearity was demonstrated over the range 0.05–100.0 ng/ml (r² = 0.99). The lower limit of quantitation was 0.05 ng/ml, which was superior to that reported in literature The method validation was evaluated by selectivity, accuracy, precision, recovery and matrix effect in agreement with the US Food and Drug Administration guidance. The method was successfully applied to a pharmacokinetic study of a novel fulvestrant microcrystal in rats after intramuscular administration. It revealed that the rate of absorption increases and the extent of absorption is constant with a decrease in microcrystal diameter.     

Determination of estrogens in water by HPLC-UV using cloud point extraction

A method based on cloud point extraction was developed to determine four kinds of estrogens: estriol (E3), estradiol (E2), estrone (E1), and progesterone (P) in water by high performance liquid chromatography separation and ultraviolet detection (HPLC-UV). The non-ionic surfactant Triton X-114 was chosen as extractant solvent. The parameters affecting extraction efficiency, such as concentrations of Triton X-114 and Na₂SO₄, equilibration temperature, equilibration time and centrifugation time were evaluated and optimized. Under the optimum conditions, preconcentration factors of 99 for E3, 73 for E2, 152 for E1 and 86 for P were obtained for 10 mL water sample. The detection of limitation was 0.23 ng mL⁻¹ for E3, 0.32 ng mL⁻¹ for E2, 0.25 ng mL⁻¹ for E1 and 5.0 ng mL⁻¹ for P. The proposed method was successfully applied to the determination of trace amount of estrogens in wastewater treatment plant (WWTP) effluent water and exposure water with 10 ng mL⁻¹ E2 for toxicological study in our lab. For the case of WWTP effluent water samples, no estrogen was found. The accuracy of the proposed method was tested by recovery measurements of spiked samples and good recoveries of 81.2-99.5% were obtained.     

DNA Interaction with 17α‐Ethinylestradiol Studied Using Electrochemical Biosensors and Biosensing in Solution

The synthetic estrogen 17α‐ethinylestradiol (EE2) is an active component of oral contraceptives. It is considered as an endocrine disrupting compound that, once incorporated into an organism, affects the hormonal balance of animals and humans. In this study we characterized the DNA‐EE2 interaction using an electrochemical biosensor and biosensing in solution phase with the double stranded DNA from salmon sperm and deoxyguanosine monophosphate (dGMP). Differential pulse voltammetry method has been applied based on voltammetric anodic responses of the deoxyguanine (dGuo) and deoxyadenine (dAdo) as well as EE2 in the medium of phosphate buffer solution pH 7.0. Binding of EE2 to the nucleobases leads to a decrease of their anodic signals. Association constant for DNA‐EE2 interaction has been estimated to be about 1.1 ? 10³ L mol^?1 and 1.4 ? 10³ L mol^?1 for dGuo and dAdo responses, respectively. The association is reversible as indicated by decrease of the EE2 response in pure buffer solution due to leaching of EE2 from the surface attached DNA. The DNA‐EE2 association has been confirmed also by UV‐vis spectrometric experiments.     

Extraction and preconcentration of 17α-ethynylestradiol as an endocrine-disrupting agent from environmental water samples by a modified magnetic nanosorbent

A rapid, simple and efficient procedure is demonstrated for extraction and determination of an endocrine-disrupting compound, synthetic estrogen, 17α-ethynylestradiol (EE2), in water and wastewater samples via magnetic solid-phase extraction followed by high-performance liquid chromatography coupled with UV detection. The analytical method is based on extraction of EE2 by dispersing magnetic nanoparticles in sample solution for a desired time and then eluting the analytes with an appropriate solvent. The nanoparticles were modified with a hydrophobic material by self-assembling an organosulfur compound (bis-(2,4,4-trimethylpentyl)-dithiophosphinic acid) onto the silver-coated Fe₃O₄ nanoparticles as sorbent. The effects of several parameters, such as amount of sorbent, sample volume, extraction time, ionic strength and desorption conditions, were examined to obtain better efficiency. The optimized methodology exhibited a good linearity between 0.5 and 100 μg L^?1 with a limit of detection (LOD) of 0.3 μg L^?1, and a preconcentration factor of 245 with intra- and inter-day precisions (relative standard deviations) 2.4 and 3.2 %, respectively. The developed method was successfully applied for extraction and determination of EE2 in different real water samples including river water, surface water and influent and effluent of a wastewater treatment plant, and satisfactory results were achieved. The method, which provides a good preconcentration factor, a low LOD and low consumption of the organic solvent, presents a rapid, simple and efficient procedure for determining EE2 in aqueous samples.     

Receptor-based 3D QSAR analysis of estrogen receptor ligands – merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods

One of the major challenges in computational approaches to drug design is the accurate prediction of binding affinity of biomolecules. In the present study several prediction methods for a published set of estrogen receptor ligands are investigated and compared. The binding modes of 30 ligands were determined using the docking program AutoDock and were compared with available X-ray structures of estrogen receptor-ligand complexes. On the basis of the docking results an interaction energy-based model, which uses the information of the whole ligand-receptor complex, was generated. Several parameters were modified in order to analyze their influence onto the correlation between binding affinities and calculated ligand-receptor interaction energies. The highest correlation coefficient (r ² = 0.617, q ² _LOO = 0.570) was obtained considering protein flexibility during the interaction energy evaluation. The second prediction method uses a combination of receptor-based and 3D quantitative structure-activity relationships (3D QSAR) methods. The ligand alignment obtained from the docking simulations was taken as basis for a comparative field analysis applying the GRID/GOLPE program. Using the interaction field derived with a water probe and applying the smart region definition (SRD) variable selection, a significant and robust model was obtained (r ² = 0.991, q ² _LOO = 0.921). The predictive ability of the established model was further evaluated by using a test set of six additional compounds. The comparison with the generated interaction energy-based model and with a traditional CoMFA model obtained using a ligand-based alignment (r ² = 0.951, q ² _LOO = 0.796) indicates that the combination of receptor-based and 3D QSAR methods is able to improve the quality of the underlying model.     

Kit-like <Superscript>18</Superscript>F-labeling of an estradiol derivative as a potential PET imaging agent for estrogen receptor-positive breast cancer

16α-¹⁸F-fluoroestradiol (¹⁸F-FES) has been developed as a promising positron emission tomography (PET) imaging agent for targeting estrogen receptor positive (ER⁺) breast cancer in the clinical trial. However, the radiosynthesis of ¹⁸F-FES often requires two steps and tough experimental conditions. Therefore, a new estradiol derivative (¹⁸F-AmBF₃-ES) was prepared by an efficient one-step ¹⁸F-radiolabeling method. The tracer was obtained in high yield (~65%) and excellent radiochemical purity (>98%) within 30 min. The uptake rate of ¹⁸F-AmBF₃-ES in ER⁺ cells was about 3.5% at 30 min. The results suggested that the tracer may be a potential PET imaging agent for ER⁺ breast cancer.     

Discovery of Terminal Oxazole-Bearing Natural Products by a Targeted Metabologenomic Approach

A targeted metabologenomic method was developed to selectively discover terminal oxazole-bearing natural products from bacteria. For this, genes encoding oxazole cyclase, a key enzyme in terminal oxazole biosynthesis, were chosen as the genomic signature to screen bacterial strains that may produce oxazole-bearing compounds. Sixteen strains were identified from the screening of a bacterial DNA library (1,000 strains) using oxazole cyclase gene-targeting polymerase chain reaction (PCR) primers. The PCR amplicon sequences were subjected to phylogenetic analysis and classified into nine clades. ¹H−¹³C coupled-HSQC NMR spectra obtained from the culture extracts of the hit strains enabled the unequivocal detection of the target compounds, including five new oxazole compounds, based on the unique ¹J_CH values and chemical shifts of oxazole: lenzioxazole ( 1 ) possessing an unprecedented cyclopentane, permafroxazole ( 2 ) bearing a tetraene conjugated with carboxylic acid, tenebriazine ( 3 ) incorporating two modified amino acids, and methyl-oxazolomycins A and B ( 4 and 5 ). Tenebriazine displayed inhibitory activity against pathogenic fungi, whereas methyl-oxazolomycins A and B ( 4 and 5 ) selectively showed anti-proliferative activity against estrogen receptor-positive breast cancer cells. This metabologenomic method enables the logical and efficient discovery of new microbial natural products with a target structural motif without the need for isotopic labeling.     

Analysis of steroids in yeast-mediated cell culture by on-line solid-phase extraction coupled high-performance liquid chromatography electrospray-ionization/mass spectrometry and novel continuous postcolumn infusion of internal standard technique

The reduction of 17-ketosteroid estrone or androstenedione to corresponding 17α- and 17β-estradiol or testosterone and epitestosterone has been performed with Saccharomyces cerevisiae. In the analysis of the cell culture, the solid-phase extraction (SPE) method was on-line coupled to high-performance liquid chromatography electrospray-ionization/mass spectrometry (HPLC-ESI/MS) for sample pretreatment to eliminate the complicated matrix interference and preconcentrate of the analytes before chromatographic separation. A novel quantification method with the continuous postcolumn infusion of internal standard was developed for the determination of substrate and products. This novel quantitative method can stabilize and enhance the ionization of all analytes during analysis. The HPLC-ESI/MS analysis of estrone, 17α-, and 17β-estradiol was operated with a negative ion mode and the analysis of androstenedione, testosterone, and epitestosterone was operated with a positive ion mode. The optimal concentration of the internal standard progesterone with the continuous postcolumn infusion technique was 3 μg mL⁻¹ for estrogen analysis and 1 ng mL⁻¹ for androgen analysis and both were at a constant infusion rate of 0.5 μL min⁻¹. All of the linear correlation coefficients of the standard calibration curves were over 0.99 and had a linear range from 0 to 50 ng mL⁻¹. The limit of detections (LODs) and the limit of quantitations (LOQs) for steroids analyzed were from 0.12 to 0.36 ng mL⁻¹ and from 0.4 to 1.2 ng mL⁻¹, respectively. The analysis accuracies and precisions were better than 94% and lower than 8.8% R.S.D., respectively. The developed method for the analysis of steroids in the cell culture was successful.     

Diethylstilbestrol glucuronide (DESG): synthesis, labeling with radioiodine and in vivo/in vitro evaluations

Diethylstilbestrol (DES) is a synthetic non-steroidal estrogen, pharmacologic effects of which resemble natural estrons; today it is being used to treat some types of postmenopausal breast cancer and advanced prostate cancer. The aim of current study is conjugation of glucuronic acid (G) to DES and to evaluate radiopharmaceutical potential of this estrogen glucuronide derivative (DESG) which is specific to β glucuronidase enzyme consisting tumor cells. Taking into consideration the compatibility to the chemical structures of the synthesized product, ¹³¹I and ¹²⁵I were chosen as the appropriate radionuclides and DESG was labeled with these radionuclides utilizing iodogen method. The radiochemical yields of ^125/131I-DESG were over 90 % according to thin layer radio chromatography method. The biodistribution of ¹³¹I-DESG in healthy female Wistar Albino rats has been investigated and the range of the breast/blood and breast/muscle ratios were approximately 2 and 13 in 240 min for ER unsaturated studies. Effects of the radioiodinated DES and DESG on the cells were examined using MCF-7, A-549, Caco-2 cell lines. ¹²⁵I-DESG has higher incorporation percentages than ¹²⁵I-DES on MCF-7 cells. The radioiodinated DESG has the desired radiopharmaceutical properties which could be candidate radiopharmaceuticals for diagnosis and especially radionuclide therapy of breast tumors.     

The electrolytic efficiency of amperometric detection in normal-phase high-performance liquid chromatography

The electrolytic efficiency of the wall-jet detector in normal-phase high-performance liquid chromatography (between 0.1 and 5%) is significantly less than its efficiency in reversed-phase separations. A large-volume wall-jet cel with a Ag/Ag⁺ reference serves as the detector system in evaluating the effects of various chromatographic conditions on efficiency. Anthraquinone, phenanthrenaquinone (both at 10^-3–10^-4 M) and three estrogen gen steroids (at 10^-2–10^-3 M) are used as samples with ethanol/ hexane eluents. The effect of pH depends on the sample; increased ethanol concentrations and lower flow rates improve the efficiency.     

Organometallic analogues of tamoxifen: Effect of the amino side-chain replacement by a carbonyl ferrocenyl moiety in hydroxytamoxifen

Since the widely prescribed selective estrogen receptor modulator (SERM) tamoxifen encounters growing cases of resistance in long-term treatments, alternative drugs with different therapeutic scopes have to be developed. Many investigators have modified the triphenylethylene scaffold, but very few have changed its amino side chain, essential for the antiestrogenic activity. For the first time, a lipophilic and stable organometallic entity, -OCH₂CO-[(η⁵-C₅H₄)FeCp], has replaced this key functional side chain, while keeping a good affinity for the estrogen receptor and an antiproliferative activity on cancer cells (MCF-7 and PC-3). Its mechanism of action is likely to be different from the antihormonal pathway followed by hydroxytamoxifen, and from the cytotoxicity observed for the ferrocifens.